Moreover, in vitro treatment of U87MG glioma cells with ciglitazone (e), 15d-PGJ2 (i) or ATRA (m) cultured in NBM+B27 with EGF+FGF resulted in 46, 72.26 and 81% inhibition of proliferation, respectively. Here, EGF is linked to central nervous system cancer.